{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T17:34:00Z","timestamp":1770831240122,"version":"3.50.1"},"reference-count":47,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2005,12,9]],"date-time":"2005-12-09T00:00:00Z","timestamp":1134086400000},"content-version":"vor","delay-in-days":4482,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arthritis &amp; Rheumatism"],"published-print":{"date-parts":[[1993,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:italic>Objective.<\/jats:italic> To determine the origin, distribution, and biologic fate of platelet\u2010derived connective tissue activating peptide\u2013III (CTAP\u2010III), to define the relative amounts of the antigen forms (CTAP\u2010III, betathromboglobulin [\u03b2\u2010TG], neutrophil activating peptide\u20132 [NAP\u20102]) in plasma of normal persons and those with rheumatic or end\u2010stage renal disease, and to define the isoforms of CTAP\u2010III in platelets, plasma, transudates, and tissue deposits.<\/jats:p><jats:p><jats:italic>Methods.<\/jats:italic> CTAP\u2010III in plasma was measured by enzyme\u2010linked immunosorbent assay, and growth promoting activity of CTAP\u2010III isoforms was tested in synovial and peritoneal cell cultures by measuring increased synthesis of <jats:sup>14<\/jats:sup>C\u2010glycosaminoglycan (<jats:sup>14<\/jats:sup>C\u2010GAG) and <jats:sup>3<\/jats:sup>H\u2010DNA. Isolated CTAP\u2010III was characterized by Western blotting, microsequencing, and mass spectrometry.<\/jats:p><jats:p><jats:italic>Results.<\/jats:italic> CTAP\u2010III was the primary isoform of this antigen family in normal platelets and platelet\u2010rich plasma; \u03b2\u2010TG and NAP\u20102 accounted for &lt;1% of CTAP\u2010III isoforms. Previously undescribed isoforms, i.e., CTAP\u2010III des 1, des 1\u20132, des 1\u20133, and a phosphate adduct of CTAP\u2010III, were observed in varying amounts. Elevated plasma levels of CTAP\u2010III antigen were found in a substantial fraction of rheumatic disease patients: 24% of those with rheumatoid arthritis, 36% of those with systemic sclerosis, and 15% of those with systemic lupus erythematosus. All 10 patients with end\u2010stage kidney disease had marked elevations of plasma CTAP\u2010III levels, which stimulated DNA and GAG synthesis by peritoneal cells in culture. Only large isoforms (such as CTAP\u2010III) were detected in venous plasma of normal subjects, rheumatic disease patients, and patients receiving long\u2010term dialysis. Normal human spleen and kidney contained substantial (\u03bc\/gm) amounts of CTAP\u2010III and traces of an isoform with the electrophoretic mobility of CTAP\u2010III des 1\u201315\/NAP\u20102. Liver, lung, and urine contained lesser (ng\/gm) amounts of CTAP\u2010III.<\/jats:p><jats:p><jats:italic>Conclusion.<\/jats:italic> These data show that, among the 10 known isoforms, intact CTAP\u2010III itself was the major circulating isoform (&gt;90%), and \u03b2\u2010TG was the most rare (0\u20131%). Deposition of CTAP\u2010III in tissues, such as synovium, spleen, and kidney, is associated with partial processing to NAP\u20102\u2013like isoforms and the potential to induce neutrophil and fibroblast activation in patients with rheumatic or end\u2010stage renal disease.<\/jats:p>","DOI":"10.1002\/art.1780360816","type":"journal-article","created":{"date-parts":[[2007,2,15]],"date-time":"2007-02-15T01:08:49Z","timestamp":1171501729000},"page":"1142-1153","source":"Crossref","is-referenced-by-count":15,"title":["Connective tissue activation. xxxvi. the origin, variety, distribution, and biologic fate of connective tissue activating peptide\u2013iii isoforms: characteristics in patients with rheumatic, renal, and arterial disease"],"prefix":"10.1002","volume":"36","author":[{"given":"C. W.","family":"Castor","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. C.","family":"Andrews","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. D.","family":"Swartz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. G.","family":"Ellis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. A.","family":"Hossler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. R.","family":"Clark","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E. L.","family":"Matteson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E. F.","family":"Sachter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2005,12,9]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.80.3.765"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1021\/bi00602a024"},{"key":"e_1_2_1_4_2","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1182\/blood.V73.6.1498.1498","article-title":"Cloning of cDNA coding for connective tissue activating peptide III from a human platelet\u2010derived ggtll expression library","volume":"73","author":"Wenger RH","year":"1989","journal-title":"Blood"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/0049-3848(78)90279-7"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(87)90284-4"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.iy.09.040191.003153"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780200316"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780220308"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02618444"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780260411"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1021\/bi00328a029"},{"key":"e_1_2_1_13_2","first-page":"504","article-title":"Connective tissue activation. XX. Stimulation of prostaglandin secretion by mediators from lymphocytes (CTAP\u20101) and platelets (CTAP\u2010III)","volume":"24","author":"Castor CW","year":"1981","journal-title":"Arthritis Rheum"},{"key":"e_1_2_1_14_2","first-page":"189","article-title":"Connective tissue activation. XVIII. Stimulation of hyaluronic acid synthetase activity","volume":"96","author":"Sisson JC","year":"1980","journal-title":"J Lab Clin Med"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780270609"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/0009-8981(81)90068-1"},{"key":"e_1_2_1_17_2","first-page":"814","article-title":"Connective tissue activation. XIX. Plasma levels of the CTAP\u2010III platelet antigen in rheumatoid arthritis","volume":"7","author":"Myers SL","year":"1980","journal-title":"J Rheumatol"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-291X(89)92330-9"},{"key":"e_1_2_1_19_2","first-page":"516","article-title":"Connective tissue activation. XXXIV. Effects of proteolytic processing on the biologic activities of CTAP\u2010III","volume":"116","author":"Castor CW","year":"1990","journal-title":"J Lab Clin Med"},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.3181\/00379727-181-42292"},{"key":"e_1_2_1_21_2","article-title":"Evidence that the anabolic and chemotactic actions of CTAP\u2010III des 1\u201015\/nap\u20102 are mediated by separate active sites","volume":"693","author":"Castor CW","year":"1992","journal-title":"Clin Res"},{"key":"e_1_2_1_22_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI114598"},{"key":"e_1_2_1_23_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.170.5.1745"},{"key":"e_1_2_1_24_2","doi-asserted-by":"publisher","DOI":"10.1002\/jlb.49.3.258"},{"key":"e_1_2_1_25_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780350712"},{"key":"e_1_2_1_26_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780310302"},{"key":"e_1_2_1_27_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780251101"},{"key":"e_1_2_1_28_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780230510"},{"key":"e_1_2_1_29_2","volume-title":"Preparation and bioassay of connective tissue activating peptide III (CTAP\u2010III) and its isoforms, Methods in Enzymology, Peptide Growth Factors","author":"Castor CW","year":"1991"},{"key":"e_1_2_1_30_2","doi-asserted-by":"publisher","DOI":"10.3181\/00379727-91-22245"},{"key":"e_1_2_1_31_2","first-page":"311","article-title":"A simple ultraviolet spectrophotometric method for the determination of protein","volume":"48","author":"Waddell WJ","year":"1956","journal-title":"J Lab Clin Med"},{"key":"e_1_2_1_32_2","volume-title":"Connective tissue activating peptides, Methods in Enzymology","author":"Castor CW","year":"1988"},{"key":"e_1_2_1_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/0003-2697(83)90022-2"},{"key":"e_1_2_1_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/0003-2697(81)90783-1"},{"key":"e_1_2_1_35_2","doi-asserted-by":"crossref","first-page":"7990","DOI":"10.1016\/S0021-9258(18)43377-7","article-title":"A gas\u2010liquid solid phase peptide protein sequenator","volume":"256","author":"Hewick RM","year":"1981","journal-title":"J Biol Chem"},{"key":"e_1_2_1_36_2","doi-asserted-by":"publisher","DOI":"10.1021\/ac00280a023"},{"key":"e_1_2_1_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/1044-0305(92)85014-B"},{"key":"e_1_2_1_38_2","unstructured":"AndrewsPC:A program for analysis of proteins with emphasis on post\u2010translational modifications: Procomp 1.0 The Third Symposium of the Protein Society. Seattle July 31 1989"},{"key":"e_1_2_1_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-291X(75)80033-7"},{"key":"e_1_2_1_40_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI112244"},{"key":"e_1_2_1_41_2","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1177\/089686088900900106","article-title":"Beta\u20102 microglobulin removal during continuous ambulatory peritoneal dialysis (CAPD)","volume":"9","author":"Lysaght MJ","year":"1989","journal-title":"Peritoneal Dial"},{"key":"e_1_2_1_42_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.6.3.312"},{"key":"e_1_2_1_43_2","first-page":"6","article-title":"Measurement of beta\u2010thromboglobulin connective tissue activating peptide\u2010III platelet antigen concentrations in pathologic synovial fluids","volume":"9","author":"Myers SL","year":"1982","journal-title":"J Rheumatol"},{"key":"e_1_2_1_44_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI105898"},{"key":"e_1_2_1_45_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(12)80297-6"},{"key":"e_1_2_1_46_2","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1001\/archinte.1980.00330200077024","article-title":"Sclerotic thickening of the peritoneal membrane in maintenance peritoneal dialysis patients","volume":"140","author":"Gandhi VC","year":"1980","journal-title":"Arch Intern Med"},{"key":"e_1_2_1_47_2","doi-asserted-by":"publisher","DOI":"10.1159\/000166799"},{"key":"e_1_2_1_48_2","doi-asserted-by":"publisher","DOI":"10.1159\/000186553"}],"container-title":["Arthritis &amp; Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fart.1780360816","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/art.1780360816","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T13:06:07Z","timestamp":1696165567000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/art.1780360816"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1993,9]]},"references-count":47,"journal-issue":{"issue":"8","published-print":{"date-parts":[[1993,9]]}},"alternative-id":["10.1002\/art.1780360816"],"URL":"https:\/\/doi.org\/10.1002\/art.1780360816","archive":["Portico"],"relation":{},"ISSN":["0004-3591","1529-0131"],"issn-type":[{"value":"0004-3591","type":"print"},{"value":"1529-0131","type":"electronic"}],"subject":[],"published":{"date-parts":[[1993,9]]}}}